The aetiology and management of Castleman disease at 50 years: Translating pathophysiology to patient care

British Journal of Haematology

Volumn 129, Issue 1, 2005, Pages 3-17

  Casper, Corey ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Angiofollicular lymph node hyperplasia; Castleman disease; Human herpesvirus 8; Lymphoproliferative disease

Indexed keywords

ALPHA INTERFERON; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; ATLIZUMAB; CIDOFOVIR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FOSCARNET; GANCICLOVIR; INTERLEUKIN 6; MONOCLONAL ANTIBODY; PREDNISONE; PROCARBAZINE; RETINOIC ACID; RITUXIMAB; THALIDOMIDE; UNCLASSIFIED DRUG; VALGANCICLOVIR; VINCRISTINE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BACTERIAL INFECTION; CHILD; CLINICAL FEATURE; CYTOKINE PRODUCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; KAPOSI SARCOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; VIRUS INFECTION;

GIANT LYMPH NODE HYPERPLASIA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; INTERLEUKIN-8;

EID: 17144417319     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05311.x     Document Type: Review

References (97)

1. Aaron, L., Lidove, O., Yousry, C., Roudiere, L., Dupont, B. & Viard, J.P. (2002) Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: the impact of highly active antiretroviral therapy. Clinical Infectious Diseases, 35, 880-882.
2. Andres, E. & Maloisel, F. (2000) Interferon-alpha as first-line therapy for treatment of multicentric Castleman's disease. Annals of Oncology, 11, 1613-1614.
3. Aoki, Y., Jaffe, E.S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P.S. & Tosato, G. (1999) Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood, 93, 4034-4043.
4. Aoki, Y., Jones, K.D. & Tosato, G. (2000) Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Journal of Hematotherapy and Stem Cell Research, 9, 137-145.
5. Aoki, Y., Tosato, G., Fonville, T.W. & Pittaluga, S. (2001) Serum viral interleukin-6 in AIDS-related multicentric Castleman disease. Blood, 97, 2526-2527.
6. Beck, J.T., Hsu, S.M., Wijdenes, J., Bataille, R., Klein, B., Vesole, D., Hayden, K., Jagannath, S. & Barlogie, B. (1994) Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. The New England Journal of Medicine, 330, 602-605.
7. Belec, L., Mohamed, A.S., Authier, F.J., Hallouin, M.C., Soe, A.M., Cotigny, S., Gaulard, P. & Gherardi, R.K. (1999a) Human herpes-virus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood, 93, 3643-3653.
8. Belec, L., Authier, F.J., Mohamed, A.S., Soubrier, M. & Gherardi, R.K. (1999b) Antibodies to human herpesvirus 8 in POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes) syndrome with multicentric Castleman's disease. Clinical Infectious Diseases, 28, 678-679.
9. Ben-Ezra, J., Johnson, D.A., Rossi, J., Cook, N. & Wu, A. (1991) Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. Journal of Histochemistry and Cytochemistry, 39, 351-354.
10. Berezne, A., Agbalika, F. & Oksenhendler, E. (2004) Failure of cidofovir in HIV-associated multicentric Castleman disease. Blood, 103, 4368-4369; author reply 4369.
11. Bertero, M.T., De Maestri, M. & Caligaris-Cappio, F. (2000) Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma. Haematologica, 85, 216-217.
12. Boivin, G., Cote, S., Cloutier, N., Abed, Y., Maguigad, M. & Routy, J.P. (2002) Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease. Journal of Medical Virology, 68, 399-403.
13. Bottieau, E., Colebunders, R., Schroyens, W., Van Droogenbroeck, J., De Droogh, E., Depraetere, K., De Raeve, H. & Van Marck, E. (2000) Multicentric Castleman's disease in 2 patients with HIV infection, unresponsive to antiviral therapy. Acta Clinica Belgica, 55, 97-101.
14. Bowne, W.B., Lewis, J.J., Filippa, D.A., Niesvizky, R., Brooks, A.D., Burt, M.E. & Brennan, M.F. (1999) The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer, 85, 706-717.
15. Brandt, S.J., Bodine, D.M., Dunbar, C.E. & Nienhuis, A.W. (1990) Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. Journal of Clinical Investigation, 86, 592-599.
16. Cangiarella, J., Gallo, L. & Winkler, B. (1997) Potential pitfalls in the diagnosis of Castleman's disease of the mediastinum on fine needle aspiration biopsy. Acta Cytologica, 41, 951-952.
17. Cannon, J.S., Nicholas, J., Orenstein, J.M., Mann, R.B., Murray, P.G., Browning, P.J., DiGiuseppe, J.A., Cesarman, E., Hayward, G.S. & Ambinder, R.F. (1999) Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. Journal of Infectious Diseases, 180, 824-828.
18. Casper, C., Nichols, W.G., Huang, M.L., Corey, L. & Wald, A. (2004) Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood, 103, 1632-1634.
19. Castleman, B. & Thowne, V.W. (eds) (1954) Case records of the Massachusetts General Hospital Weekly Clinicopathological Exercises: Case 40011. The New England Journal of Medicine, 250, 26-30.
20. Castleman, B., Iverson, L. & Menendez, V.P. (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer, 9, 822-830.
21. Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M. & Moore, P.S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266, 1865-1869.
22. Chronowski, G.M., Ha, C.S., Wilder, R.B., Cabanillas, F., Manning, J. & Cox, J.D. (2001) Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer, 92, 670-676.
23. Cokelaere, K., Debiec-Rychter, M., De Wolf-Peeters, C., Hagemeijer, A. & Sciot, R. (2002) Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis. American Journal of Surgical Pathology, 26, 662-669.
24. Corbellino, M., Poirel, L., Aubin, J.T., Paulli, M., Magrini, U., Bestetti, G., Galli, M. & Parravicini, C. (1996) The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease). Clinical Infectious Diseases, 22, 1120-1121.
25. Corbellino, M., Bestetti, G., Scalamogna, C., Calattini, S., Galazzi, M., Meroni, L., Manganaro, D., Fasan, M., Moroni, M., Galli, M. & Parravicini, C. (2001) Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood, 98, 3473-3475.
26. Dispenzieri, A., Kyle, R.A., Lacy, M.Q., Rajkumar, S.V., Therneau, T.M., Larson, D.R., Greipp, P.R., Witzig, T.E., Basu, R., Suarez, G.A., Fonseca, R., Lust, I.A. & Gertz, M.A. (2003) POEMS syndrome: definitions and long-term outcome. Blood, 101, 2496-2506.
27. Dupin, N., Diss, T.L., Kellam, P., Tulliez, M., Du, M.Q., Sicard, D., Weiss, R.A., Isaacson, P.G. & Boshoff, C. (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood, 95, 1406-1412.
28. Flendrig, J.A. (1969) Benign giant lymphoma: the clinical signs and symptoms and the morphological aspects. Folia Medica, 12, 119-120.
29. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Mediane, 1, 27-31.
30. Foss, H.D., Araujo, I., Demel, G., Klotzbach, H., Hummel, M. & Stein, H. (1997) Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. Journal of Pathology, 183, 44-50.
31. Franks, M.E., Macpherson, G.R. & Figg, W.D. (2004) Thalidomide. The Lancet, 363, 1802-1811.
32. Frizzera, G. (1988) Castleman's disease and related disorders. Seminars in Diagnostic Pathology, 5, 346-364.
33. Frizzera, G., Peterson, B.A., Bayrd, E.D. & Goldman, A. (1985) A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. Journal of Clinical Oncology, 3, 1202-1216.
34. Gaba, A.R., Stein, R.S., Sweet, D.L. & Variakojis, D. (1978) Multicentric giant lymph node hyperplasia. American Journal of Clinical Pathology, 69, 86-90.
35. Gholam, D., Vantelon, J.M., Al-Jijakli, A. & Bourhis, J.H. (2003) A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Annals of Hematology, 82, 766-768.
36. Grandadam, M., Dupin, N., Calvez, V., Gorin, I., Blum, L., Kernbaum, S., Sicard, D., Buisson, Y., Agut, H., Escande, J.P. & Huraux, J.M. (1997) Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. Journal of Infectious Diseases, 175, 1198-1201.
37. Grundhoff, A. & Ganem, D. (2004) Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. Journal of Clinical Investigation, 113, 124-136.
38. Hall, P.A., Donaghy, M., Cotter, F.E., Stansfeld, A.G. & Levison, D.A. (1989) An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology, 14, 333-346; discussion 429-332.
39. Hanson, C.A., Frizzera, G., Patton, D.F., Peterson, B.A., McClain, K.L., Gajl-Peczalska, K.J. & Kersey, J.H. (1988) Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman's disease. Association with Epstein-Barr virus. American Journal of Pathology, 131, 84-91.
40. Herrada, J., Cabanillas, F., Rice, L., Manning, J. & Pugh, W. (1998) The clinical behavior of localized and multicentric Castleman disease. Annals of Internal Medicine, 128, 657-662.
41. Ide, M., Ogawa, E., Kasagi, K., Kawachi, Y. & Ogino, T. (2003) Successful treatment of multicentric Castleman's disease with bilateral orbital tumour using rituximab. British Journal of Haematology, 121, 818-819.
42. Jung, C.P., Emmerich, B., Goebel, F.D. & Bogner, J.R. (2004) Successful treatment of a patient with HIV-associated multicentric Castleman disease (MCD) with thalidomide. American Journal of Hematology, 75, 176-177.
43. Kane, K.P., Langman, M.J. & Williams, G.R. (1996) Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. Cancer Research, 56, 623-632.
44. Katano, H., Sato, Y., Kurata, T., Mori, S. & Sata, T. (2000) Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology, 269, 335-344.
45. Katano, H., Sato, Y., Itoh, H. & Sata, T. (2001) Expression of human herpesvirus 8 (HHV-8)-encoded immediate early protein, open reading frame 50, in HHV-8-associated diseases. Journal of Human Virology, 4, 96-102.
46. Kedes, D.H. & Ganem, D. (1997) Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. Journal of Clinical Investigation, 99, 2082-2086.
47. Keller, A.R., Hochholzer, L. & Castleman, B. (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer, 29, 670-683.
48. Kikuta, H., Itakura, O., Ariga, T. & Kobayashi, K. (1997) Detection of human herpesvirus 8 DNA sequences in peripheral blood mononuclear cells of children. Journal of Medical Virology, 53, 81-84.
49. Kishimoto, T., Akira, S., Narazaki, M. & Taga, T. (1995) Interleukin-6 family of cytokines and gp130. Blood, 86, 1243-1254.
50. Ko, S.F., Hsieh, M.J., Ng, S.H., Lin, J.W., Wan, Y.L., Lee, T.Y., Chen, W.J. & Chen, M.C. (2004) Imaging spectrum of Castleman's disease. AJR. American Journal of Roentgenology, 182, 769-775.
51. Kofteridis, D.P., Tzagarakis, N., Mixaki, I., Maganas, E., Xilouri, E., Stathopoulos, E.N., Eliopoulos, G.D. & Gikas, A. (2004) Multicentric Castleman's disease: prolonged remission with and CD-20 monoclonal antibody in an HIV-infected patient. AIDS, 18, 585-586.
52. Kumari, P., Schechter, G.P., Saini, N. & Benator, D.A. (2000) Successful treatment of human immunodeficiency virus-related Castleman's disease with interferon-alpha. Clinical Infectious Diseases, 31, 602-604.
53. Lee, F.C. & Merchant, S.H. (2003) Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide. American Journal of Hematology, 73, 48-53.
54. Loi, S., Goldstein, D., Clezy, K., Milliken, S., Hoy, J. & Chipman, M. (2004) Castleman's disease and HIV infection in Australia. HIV Medicine, 5, 157-162.
55. Marcelin, A.-G., Aaron, L., Mateus, C., Cyan, E., Gorin, I., Viard, J.-P., Calvez, V. & Dupin, N. (2003) Rituximab therapy for HIV-associated Castleman disease. Blood, 102, 2786-2788.
56. Marietta, M., Pozzi, S., Luppi, M., Bertesi, M., Cappi, C., Morselli, M. & Torelli, G. (2003) Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report. European Journal of Haematology, 70, 181-182.
57. Martin, J.M., Bell, B. & Ruether, B.A. (1985) Giant lymph node hyperplasia (Castleman's disease) of hyaline vascular type. Clinical heterogeneity with immunohistologic uniformity. American Journal of Clinical Pathology, 84, 439-446.
58. Medveczky, M.M., Horvath, E., Lund, T. & Medveczky, P.G. (1997) In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS, 11, 1327-1332.
59. Menke, D.M. & DeWald, G.W. (2001) Lack of cytogenetic abnormalities in Castleman's disease. Southern Medical Journal, 94, 472-474.
60. Menke, D.M., Tiemann, M., Camoriano, J.K., Chang, S.F., Madan, A., Chow, M., Habermann, T.M. & Parwaresch, R. (1996) Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. American Journal of Clinical Pathology, 105, 268-276.
61. Menke, D.M., Isaacson, P.G. & Boshoff, C. (2000) Ly-1b cells and Castleman disease. Blood, 96, 1614-1616.
62. Menke, D.M., Chadbum, A., Cesarman, E., Green, E., Berenson, J., Said, J., Tiemann, M., Parwaresch, R. & Thome, S.D. (2002) Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection. American Journal of Clinical Pathology, 117, 268-275.
63. Moore, D.F., Preti, A. & Tran, S.M. (1996a) Prognostic implications following an indeterminate diagnostic work-up of lymphoma. Blood, 88 (Suppl. 1), 229a (abstract).
64. Moore, P.S., Boshoff, C, Weiss, R.A. & Chang, Y. (1996b) Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science, 274, 1739-1744.
65. Murray, P.G., Deacon, E., Young, L.S., Barletta, J.M., Mann, R.B., Ambinder, R.F., Rowlands, D.C., Jones, E.L., Ramsay, A.D. & Crocker, J. (1995) Localization of Epstein-Barr virus in Castleman's disease by in situ hybridization and immunohistochemistry. Hematologic Pathology, 9, 17-26.
66. Nakanishi, T., Sobue, I., Toyokura, Y., Nishitani, H., Kuroiwa, Y., Satoyoshi, E., Tsubaki, T., Igata, A. & Ozaki, Y. (1984) The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology, 34, 712-720.
67. Newsom-Davis, T., Bower, M., Wildfire, A., Thirlwell, C., Nelson, M., Gazzard, B. & Stebbing, J. (2004) Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels. Leukemia and Lymphoma, 45, 1939-1941.
68. Neyts, J. & De Clercq, E. (1997) Antiviral drug susceptibility of human herpesvirus 8. Antimicrobial Agents and Chemotherapy, 41, 2754-2756.
69. Nishi, J., Arimura, K., Utsunomiya, A., Yonezawa, S., Kawakami, K., Maeno, N., Ijichi, O., Ikarimoto, N., Nakata, M., Kitajima, I., Fukushige, T., Takamatsu, H., Miyata, K. & Maruyama, I. (1999) Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease. British Journal of Haematology, 104, 482-485.
70. Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T. & Yoshizaki, K. (2000) Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood, 95, 56-61.
71. Nord, J.A. & Karter, D. (2003) Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease. International Journal of STD and AIDS, 14, 61-62.
72. Ohyashiki, J.H., Ohyashiki, K., Kawakubo, K., Serizawa, H., Abe, K., Mikata, A. & Toyama, K. (1994) Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type. American Journal of Clinical Pathology, 101, 290-295.
73. Okamoto, I., Iyonaga, K., Fujii, K., Mori, T., Yoshioka, M., Kohrogi, H., Matsumoto, M. & Suga, M. (2003) Absence of gallium uptake in unicentric and multicentric Castleman's disease. Internal Medicine, 42, 735-739.
74. Oksenhendler, E., Duarte, M., Soulier, J., Cacoub, P., Welker, Y., Cadranel, J., Cazals-Hatem, D., Autran, B., Clauvel, J.P. & Raphael, M. (1996) Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS, 10, 61-67.
75. Oksenhendler, E., Carcelain, G., Aoki, Y., Boulanger, E., Maillard, A., Clauvel, J.P. & Agbalika, F. (2000) High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood, 96, 2069-2073.
76. Oksenhendler, E., Boulanger, E., Galicier, L., Du, M.Q., Dupin, N., Diss, T.C., Hamoudi, R., Daniel, M.T., Agbalika, F., Boshoff, C., Clauvel, J.P., Isaacson, P.G. & Meignin, V. (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood, 99, 2331-2336.
77. Parez, N., Bader-Meunier, B., Roy, C.C. & Dommergues, J.P. (1999) Paediatric Castleman disease: report of seven cases and review of the literature. European Journal of Pediatrics, 158, 631-637.
78. Parravinci, C., Corbellino, M., Paulli, M., Magrini, U., Lazzarino, M., Moore, P.S. & Chang, Y. (1997) Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. American Journal of Pathology, 151, 1517-1522.
79. Peterson, B.A. & Frizzera, G. (1993) Multicentric Castleman's disease. Seminars in Oncology, 20, 636-647.
80. Reddy, M.P. & Graham, M.M. (2003) FDG positron emission tomographic imaging of thoracic Castleman's disease. Clinical Nuclear Medicine, 28, 325-326.
81. Revuelta, M.P. & Nord, J.A. (1998) Successful treatment of multicentric Castleman's disease in a patient with human immunodeficiency virus infection. Clinical Infectious Diseases, 26, 527.
82. Rieu, P., Droz, D., Gessain, A., Grünfeld, J-P. & Hermine, O. (1999) Retinoic acid for treatment of multicentric Castleman's disease. The Lancet, 354, 1262-1263.
83. Salisbury, J.R. (1990) Castleman's disease in childhood and adolescence: report of a case and review of literature. Pediatric Pathology, 10, 609-615.
84. Sato, K., Tsuchiya, M., Saldanha, J., Koishihara, Y., Ohsugi, Y., Kishimoto, T. & Bendig, M.M. (1993) Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Research, 53, 851-856.
85. Senanayake, S., Kelly, J., Lloyd, A., Waliuzzaman, Z., Goldstein, D. & Rawlinson, W. (2003) Multicentric Castleman's disease treated with antivirals and immunosuppressants. Journal of Medical Virology, 71, 399-403.
86. Soubrier, M.J., Dubost, J.J. & Sauvezie, B.J. (1994) POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. American Journal of Medicine, 97, 543-553.
87. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M.F., Clauvel, J.P., Raphael, M., Degos, L. (1995a) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood, 86, 1276-1280.
88. Soulier, J., Grollet, L., Oksenhendler, E., Miclea, J.M., Cacoub, P., Baruchel, A., Brice, P., Clauvel, J.P., d'Agay, M.F., Raphael, M. (1995b) Molecular analysis of clonality in Castleman's disease. Blood, 86, 1131-1138.
89. Stansby, G., Hilson, A. & Hamilton, G. (1991) Gallium scintigraphy in the diagnosis and management of multifocal Castleman's disease. British Journal of Radiology, 64, 165-167.
90. Suda, T., Katano, H., Delsol, G., Kakiuchi, C., Nakamura, T., Shiota, M., Sata, T., Higashihara, M. & Mori, S. (2001) HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease. Pathology International, 51, 671-679.
91. Summerfield, G.P., Taylor, W., Bellingham, A.J. & Goldsmith, H.J. (1983) Hyaline-vascular variant of angiofollicular lymph node hyperplasia with systemic manifestations and response to corticosteroids. Journal of Clinical Pathology, 36, 1005-1011.
92. Weisenburger, D.D., Nathwani, B.N., Winberg, C.D. & Rappaport, H. (1985) Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Human Pathology, 16, 162-172.
93. Yamasaki, S., Iino, T., Nakamura, M., Henzan, H., Ohshima, K., Kikuchi, M., Otsuka, T. & Harada, M. (2003) Detection of human herpesvirus-8 in peripheral blood mononuclear cells from adult Japanese patients with multicentric Castleman's disease. British Journal of Haematology, 120, 471-477.
94. Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H. & Komori, T. (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood, 74, 1360-1367.
95. Zancai, P., Cariati, R., Quaia, M., Guidoboni, M., Rizzo, S., Boiocchi, M. & Dolcetti, R. (2004) Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes. International Journal of Oncology, 25, 345-355.
96. Zietz, C., Bogner, J.R., Goebel, F.D. & Lohrs, U. (1999) An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS. The New England Journal of Medicine, 340, 1923-1924.
97. Zoeteweij, J.P., Eyes, S.T., Orenstein, J.M., Kawamura, T., Wu, L., Chandran, B., Forghani, B. & Blauvelt, A. (1999) Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents. Journal of Virology, 73, 5894-5902.